Search Results
Neelima Denduluri, MD, elaborates on the SOPHIA trial data in HER+ metastatic breast cancer
Neelima Denduluri, MD, regarding the MONALEESA-7 trial in premenopausal metastatic breast cancer
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials
Margetuximab Plus Chemotherapy in HER2+ Breast Cancer
Margetuximab for the treatment of HER2-positive breast cancer
Dr. Catenacci on Study of Margetuximab Plus Pembrolizumab in Gastric:GEJ Cancer
Webinar: Metastatic Breast Cancer - New Therapy Optionis
